Piperacillin‐tazobactam pharmacokinetics in patients with intraabdominal infections

SS Jhee, JW Kern, JP Burm, AE Yellin… - … : The Journal of …, 1995 - Wiley Online Library
Study Objective. To determine the appropriate compartmental and noncompartmental
pharmacokinetic parameters for intravenous piperacillin and tazobactam. Design …
被引用次数：16 相关文章

Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections

SS Jhee, JW Kern, JP Burm, AE Yellin… - …, 1995 - pubmed.ncbi.nlm.nih.gov
Study objective To determine the appropriate compartmental and noncompartmental
pharmacokinetic parameters for intravenous piperacillin and tazobactam. Design Sequential …

Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.

SS Jhee, JW Kern, JP Burm, AE Yellin, MA Gill - Pharmacotherapy, 1995 - europepmc.org
Interventions Patients received piperacillin 4 g plus tazobactam 500 mg by intravenous
intermittent infusion every 8 hours. Measurements and main results The estimated …

[引用][C] Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections

SS JHEE, JW KERN, JP BURM, AE YELLIN… - …, 1995 - pascal-francis.inist.fr
Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

[引用][C] Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections

SS JHEE, JW KERN, JP BURM, AE YELLIN… - …, 1995 - Pharmacotherapy